Role of glucagon-like peptide 1 receptor agonists in management of obesity
But really we have no idea how this plays out in [pregnant] humans, and we wont have that data for years. Despite the lack of clarity on what this drug could do to women, the concerns have not been relayed in advertising in the US or in media coverage
Product and pharmacy selection Whether you end up on a semaglutide or tirzepatide preparation, and whether it is an FDA-approved brand filled at retail or a compounded formulation from a 503A pharmacy, shifts the total more than any promotional line does
Research has established correlations between low glycine levels and insulin resistance, with people who have obesity, prediabetes, and non-alcoholic fatty liver disease consistently showing lower circulating glycine concentrations compared to metabolically healthy individuals
Mechanical trauma and local irritation represent the most common cause of injection site reactions
Air bubbles in the syringe Small air bubbles are not dangerous when injecting subcutaneously
